{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:10:25Z","timestamp":1697328625623},"reference-count":24,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,26]],"date-time":"2006-01-26T00:00:00Z","timestamp":1138233600000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>For the treatment of secondary hyperparathyroidism (HPTH\u2010II) in dialysis patients and hypercalcemia in patients with parathyroid carcinoma. Calcimimetics are a new class of drugs approved in the European Community and the United States by the Food and Drug Administration that were designed to suppress parathyroid hormone (PTH) levels with a simultaneous reduction in serum calcium and phosphorus levels, and calcium phosphorus product (Ca \u00d7 P). Hypocalcemia is a frequent finding during the correction phase of the HPTH\u2010II with calcimimetics. By contrast, the appearance of a hypercalcemia has yet to be described. In this paper, we report a case of severe hypercalcemia of immobilization in a 40\u2010year\u2010old hemodialyzed woman treated by cinacalcet HCl for a severe HPTH\u2010II (PTH&gt;1,000\u2003pg\/mL). A kidney transplantation recipient 1983 to 1995, she was diagnosed with Charcot\u2010Marie Tooth disease in 1991. She had multiple orthopedic interventions for kidney\u2010related osteoarticular problems probably favored by the kidney graft and the immunosuppressive treatment. While she was receiving the maximum dose of 180\u2003mg\/day of cinacalcet HCl and PTH at 443\u2003pg\/mL, she needed to be hospitalized for a right hip prothesis. Two weeks after the intervention she developed a symptomatic hypercalcemia of 3.57\u2003mmol\/L which was resistant to several measures including lowering the calcium concentration in the dialysate, withdrawing all vitamin D and calcium supplementation and the administration of calcitonin. Her serum calcium level was finally stabilized in the 2.37\u20132.95\u2003mmol\/L by administration of a single intravenous dose of pamidronate. This observation illustrates that the pharmacological activation of the parathyroid CaR and other putative CaR on bone cells by calcimimetics did not protect against the occurrence of hypercalcemia of immobilization favored by a severe HPTH\u2010II in a hemodialysis patient.<\/jats:p>","DOI":"10.1111\/j.1542-4758.2006.01171.x","type":"journal-article","created":{"date-parts":[[2006,1,26]],"date-time":"2006-01-26T13:35:35Z","timestamp":1138282535000},"page":"29-34","source":"Crossref","is-referenced-by-count":1,"title":["Looking at calcimimetics impact on hypercalcemia of immobilization: Hypotheses and a case study"],"prefix":"10.1111","volume":"10","author":[{"given":"St\u00e9phane","family":"ROUEFF","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine SAINT","family":"GEORGES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van Thoai","family":"CHUONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelhamid","family":"ABBASSI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"GU\u00c9DON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie C.","family":"de VERNEJOUL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo URE\u00f1A","family":"TORRES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,26]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031633"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00720.x"},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.67139.x"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000050224.03126.AD"},{"key":"e_1_2_3_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.2003.07262.x"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1050"},{"key":"e_1_2_3_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00183.x"},{"key":"e_1_2_3_9_2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman WG","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1053"},{"key":"e_1_2_3_11_2","first-page":"309","article-title":"Calcium metabolism in space flight","volume":"8","author":"Neuman WF.","year":"1970","journal-title":"Life Sci Space Res"},{"key":"e_1_2_3_12_2","first-page":"1136","article-title":"Calcium homeostasis in immobilization","volume":"306","author":"Stewart AF","year":"1982","journal-title":"An example of resorptive hypercalciuria"},{"key":"e_1_2_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70272-1"},{"key":"e_1_2_3_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5981.468"},{"key":"e_1_2_3_15_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/08860228309076050","article-title":"Hypophosphatemia\u2010induced hypercalcemia during acute renal failure","volume":"7","author":"Gagnon RF","year":"1983","journal-title":"Clin Exp Dial Apheresis"},{"key":"e_1_2_3_16_2","first-page":"S1","article-title":"Members at KDab","volume":"42","author":"Eknoyan G","year":"2003","journal-title":"Clinical practice guidelines for bone metabolism and disease in chronic kidney disease"},{"key":"e_1_2_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(99)00263-X"},{"key":"e_1_2_3_18_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.1.239"},{"key":"e_1_2_3_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200307000-00002"},{"key":"e_1_2_3_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0306141101"},{"key":"e_1_2_3_21_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevEukaryotGeneExpr.v13.i24.30"},{"key":"e_1_2_3_22_2","first-page":"572A","article-title":"The effects of one\u2010year treatment with the calcimimetic AMG\u2010073 on bone health in ESRD patients with secondary hyperparathyroidism (SHPT)","volume":"13","author":"Quarles L","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_3_23_2","first-page":"573A","article-title":"Single doses of the calcimimetic AMG\u2010073 reduce parathyroid hormone levels in a dose dependent manner in hemodialysis patients with secondary hyperparathyroidism","volume":"11","author":"Coburn JW","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_3_24_2","first-page":"120","article-title":"Short\u2010term effects of parathyroidectomy on plasma biochemistry in chronic uremia","volume":"36","author":"Ure\u00f1a P","year":"1989","journal-title":"A prospective study"},{"key":"e_1_2_3_25_2","first-page":"P073","article-title":"Down\u2010regulation of Ca2+ transporters in kidney and duodenum by the calcimimetic compound NPS R\u2010467 (abstract)","volume":"14","author":"Abel M","year":"2003","journal-title":"J Am Soc Nephrol"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1542-4758.2006.01171.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:29:55Z","timestamp":1697326195000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1542-4758.2006.01171.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1111\/j.1542-4758.2006.01171.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1542-4758.2006.01171.x","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}